A GLP-1 agonist (like semaglutide) turns down hunger signals, but GLP-1/GIP receptor agonists improve how the body handles glucose and insulin at the same time, says Niazi
al., National trends in prescription drug expenditures and projections for 2022, American Journal of Health-System Pharmacy , 2022
[1] [2] Administration: Lipo-B comes as an injectable solution to be given intramuscularly (into a muscle)
PLoS ONE 7 , e48175 (2012)
More specifically, KEAP1 homodimerizes [124], binds to the ETGE and DLG motifs on Neh2 domain of NRF2, and also acts as a substrate adaptor protein [154] for the KEAP1-NEDD8-CUL3-RBX1 E3 ubiquitin ligase complex [119, 120, 155]
The medication activates GLP-1 receptors found throughout the body, including in immune cells, blood vessels, and even the brain